Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

Clinical trial NCT06998940 · RECRUITING

Trial details

NCT number: NCT06998940
Sponsor: SWOG Cancer Research Network
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Locally Advanced Pancreatic Adenocarcinoma Metastatic Pancreatic Adenocarcinoma Stage III Pancreatic Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8 Unresectable Pancreatic Adenocarcinoma

Start date: 2026-05-13
Primary completion: 2029-12-31
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.